197 related articles for article (PubMed ID: 23089714)
1. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.
Pavkov ME; Knowler WC; Hanson RL; Williams DE; Lemley KV; Myers BD; Nelson RG
Am J Kidney Dis; 2013 Jul; 62(1):33-41. PubMed ID: 23347458
[TBL] [Abstract][Full Text] [Related]
3. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of serum cystatin C in chronic kidney disease: a meta-analysis.
Wei L; Ye X; Pei X; Wu J; Zhao W
Clin Nephrol; 2015 Aug; 84(2):86-94. PubMed ID: 26200185
[TBL] [Abstract][Full Text] [Related]
5. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.
Pottel H; Delanaye P; Schaeffner E; Dubourg L; Eriksen BO; Melsom T; Lamb EJ; Rule AD; Turner ST; Glassock RJ; De Souza V; Selistre L; Goffin K; Pauwels S; Mariat C; Flamant M; Ebert N
Nephrol Dial Transplant; 2017 Mar; 32(3):497-507. PubMed ID: 28089986
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy.
Chen H; Li H
Clin Lab; 2017 Feb; 63(2):241-247. PubMed ID: 28182344
[TBL] [Abstract][Full Text] [Related]
7. Improved glomerular filtration rate estimation using new equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients.
Guo X; Qin Y; Zheng K; Gong M; Wu J; Shou W; Cheng X; Xia L; Xu E; Li X; Qiu L
Clin Biochem; 2014 Sep; 47(13-14):1220-6. PubMed ID: 24886770
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.
Jeon YL; Kim MH; Lee WI; Kang SY
Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
[TBL] [Abstract][Full Text] [Related]
12. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease.
Bevc S; Hojs R; Ekart R; Završnik M; Gorenjak M; Puklavec L
Exp Diabetes Res; 2012; 2012():179849. PubMed ID: 23008697
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
[TBL] [Abstract][Full Text] [Related]
14. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
[TBL] [Abstract][Full Text] [Related]
15. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
[TBL] [Abstract][Full Text] [Related]
16. The role of serum cystatin C in estimation of renal function in survivors of critical illness.
Eiamcharoenying J; Kulvichit W; Lumlertgul N; Chaiwatanarat T; Peerapornratana S; Srisawat N
J Crit Care; 2020 Oct; 59():201-206. PubMed ID: 32688168
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.
Ghys LF; Paepe D; Lefebvre HP; Reynolds BS; Croubels S; Meyer E; Delanghe JR; Daminet S
J Vet Intern Med; 2016 Jul; 30(4):1074-82. PubMed ID: 27461722
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients.
Zhou Z; Liu XQ; Zhang SQ; Qi XM; Zhang Q; Yard B; Wu YG
Amino Acids; 2021 May; 53(5):687-700. PubMed ID: 33811534
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
[TBL] [Abstract][Full Text] [Related]
20. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
